Gildan's Q2 reflects HanesBrands boost; raised guidance and $220M tariff refund

What happened

Gildan's Q2 2026 results incorporated the HanesBrands acquisition for the first time, driving a raised earnings outlook and signaling that integration synergies are materializing faster than expected. Management also announced an anticipated $220 million in IEEPA tariff refunds, a cash windfall that will significantly improve near‑term liquidity and accelerate deleveraging. Together, these developments reduce the execution risk that had previously weighed on the stock, as the combined entity demonstrates greater top‑ and bottom‑line momentum. The tariff refund, while one‑time, provides a cushion against any residual trade‑policy uncertainty and reinforces Gildan’s ability to manage complex regulatory environments. Overall, the cost‑leadership thesis is strengthened by tangible evidence of synergy capture and a stronger‑than‑expected financial position.

Implication

The closing of the HanesBrands deal and the upward revision to 2026 earnings confirm that integration is proceeding well, with the $200m+ synergy target now more credible than when it was announced. The $220 million IEEPA refund is a one‑time but significant cash boost that will lower net debt, reducing financial risk and potentially enabling accelerated returns to shareholders. While the acquisition adds complexity and higher fixed costs, the improved margin and cash‑flow trajectory imply that the combined entity can absorb these challenges more comfortably. With the major deal‑closure overhang removed and execution tracking ahead of plan, Gildan’s risk/reward profile has tilted meaningfully upward. We reiterate a BUY rating with heightened conviction, expecting the market to re‑rate the stock as synergy delivery becomes evident in subsequent quarters.

Thesis delta

The thesis strengthens materially as the HanesBrands acquisition has now closed and is already contributing to raised guidance, confirming that synergy capture is ahead of schedule. The unexpected $220 million IEEPA tariff refund provides a non‑recurring cash infusion that accelerates deleveraging and reduces near‑term financial risk, directly addressing one of the key concerns in the prior report. As a result, execution risk is lower and the path to achieving the targeted synergies and credit improvement is clearer, warranting a more confident BUY stance.